The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 19, 2025

Filed:

Nov. 03, 2020
Applicants:

Geron Corporation, Foster City, CA (US);

Icahn School of Medicine AT Mount Sinai, New York, NY (US);

Inventors:

Xiaoli Wang, New York, NY (US);

Fei Huang, Foster City, CA (US);

Assignee:

Geron Corporation, Foster City, CA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/11 (2006.01); A61K 31/506 (2006.01); A61K 31/519 (2006.01); A61K 31/529 (2006.01); A61K 31/5377 (2006.01); C12N 15/113 (2010.01);
U.S. Cl.
CPC ...
C12N 15/1137 (2013.01); A61K 31/506 (2013.01); A61K 31/519 (2013.01); A61K 31/529 (2013.01); A61K 31/5377 (2013.01); C12N 2310/315 (2013.01); C12N 2310/3515 (2013.01);
Abstract

Aspects of the disclosure include methods for treating a myeloproliferative neoplasm. Methods according to certain embodiments include co-administering to a subject a Janus kinase (JAK) inhibitor and a telomerase inhibitor comprising an oligonucleotide and a lipid moiety linked to the 5' and/or 3′ end of the oligonucleotide. Methods for inducing apoptosis of a myeloproliferative neoplasm cell by contacting the cell with an amount of a JAK inhibitor and a telomerase inhibitor sufficient to induce apoptosis are also described. Compositions having a JAK inhibitor and a telomerase inhibitor for practicing the subject methods are also provided.


Find Patent Forward Citations

Loading…